| Date | Form | Description | Docs | XBRL | Pages |
| 06/14/02 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 03/14/02 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 09/14/01 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
18 | |
| 06/14/01 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
22 | |
| 03/19/01 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 09/14/00 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
15 | |
| 06/13/00 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 03/15/00 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 09/13/99 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
15 | |
| 06/14/99 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
25 |
Latest News & Events
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Read More...Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Read More...